Journal of Inflammation (United Kingdom)

SJR Rank #3,062H-index: 75SJR: 1.323Best quartile: Q1Open AccessAPC: US$3,190Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

BioMed Central Ltd

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.350.71.051.4

Subject Categories

  • Clinical BiochemistryQ1
  • Cell BiologyQ2

Areas: Biochemistry, Genetics and Molecular Biology

Most published research topics

Immune Response and InflammationAsthma and respiratory diseasesImmune cells in cancerNeutrophil, Myeloperoxidase and Oxidative MechanismsAdipokines, Inflammation, and Metabolic DiseasesInflammasome and immune disordersCell Adhesion Molecules ResearchChronic Obstructive Pulmonary Disease (COPD) ResearchIL-33, ST2, and ILC PathwaysNeuroinflammation and Neurodegeneration Mechanisms

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0306090120

Documents per Year

20222025015304560

Detailed Information

ISSN

1476-9255

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

5.33

References per Document

53.02

Coverage

2004-2026

Scope

Journal of Inflammation welcomes research submissions on all aspects of inflammation. The five classical symptoms of inflammation, namely redness (rubor), swelling (tumour), heat (calor), pain (dolor) and loss of function (functio laesa), are only part of the story. The term inflammation is taken to include the full range of underlying cellular and molecular mechanisms involved, not only in the production of the inflammatory responses but, more importantly in clinical terms, in the healing process as well. Thus the journal covers molecular, cellular, animal and clinical studies, and related aspects of pharmacology, such as anti-inflammatory drug development, trials and therapeutic developments. It also considers publication of negative findings. Journal of Inflammation aims to become the leading online journal on inflammation and, as online journals replace printed ones over the next decade, the main open access inflammation journal. Open access guarantees a larger audience, and thus impact, than any restricted access equivalent, and increasingly so, as the escalating costs of printed journals puts them outside University budgets. The unrestricted access to research findings in inflammation aids in promoting dynamic and productive dialogue between industrial and academic members of the inflammation research community, which plays such an important part in the development of future generations of anti-inflammatory therapies.

Metrics from SCImago Journal Rank 2025. View on SCImago